Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$86,926,311
New position
Shares Held
342,270
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#328
of 4,664 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STOREBRAND ASSET MANAGEMENT AS holds $1,607,022,504 across 10 Drug Manufacturers - General names. JNJ ranks #8 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
471,742 | $565,821,554 | |
| 2 | ABBV |
AbbVie Inc.
|
1,078,470 | $271,386,190 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,685,911 | $216,639,563 | |
| 4 | PFE |
Pfizer Inc
|
5,190,196 | $124,979,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
939,277 | $118,668,256 | |
| 6 | AMGN |
Amgen Inc
|
325,992 | $118,048,223 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,753,508 | $101,037,130 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
342,270 | $86,926,311 |
All Filings in JNJ
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,926,311 | 342,270 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||